The objectives of the STREXIT 2 Project in the words of Principal Investigator and Co-Leader Dr Winan van Houdt
STREXIT 2 is part of a series of clinical trials funded by the Horizon Europe programme as part of the EU Mission on Cancer. The twelve clinical trials, led by multistakeholder and multidisciplinary consortiums, form together the European Cancer Cluster.
